{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:42:06Z","timestamp":1780461726117,"version":"3.54.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.semdp.2025.150960","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:19:57Z","timestamp":1760109597000},"page":"150960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bridging Perspectives: Integrating urologist and cytopathologist insights of urine cytology"],"prefix":"10.1016","volume":"42","author":[{"given":"Nikka","family":"Khorsandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Porten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"VandenBussche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-4465","authenticated-orcid":false,"given":"Poonam","family":"Vohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semdp.2025.150960_bib0001","series-title":"Bladder Cancer","year":"2024"},{"key":"10.1016\/j.semdp.2025.150960_bib0002","unstructured":"National Cancer Institute. Cancer stat facts: bladder cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html. Published 2024. Accessed December 4, 2024."},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0003","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.semdp.2025.150960_bib0004","series-title":"Comprehensive Diagnostic Approach to Bladder Cancer","author":"Bjurlin","year":"2021"},{"key":"10.1016\/j.semdp.2025.150960_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2147\/CEOR.S274951","article-title":"Humanistic and economic burden of non-muscle invasive bladder cancer: results of two systematic literature reviews","volume":"12","author":"Lee","year":"2020","journal-title":"Clin Outcomes Res"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0006","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0007","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1590\/s1677-5538.ibju.2020.99.01","article-title":"Bladder preservation in muscle-invasive bladder cancer: a comprehensive review","volume":"46","author":"Hamad","year":"2020","journal-title":"Int Braz J Urol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0008","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10.1016\/j.semdp.2025.150960_bib0009","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0011","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0266462310001364","article-title":"Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis","volume":"27","author":"Mowatt","year":"2011","journal-title":"Int J Technol Assess Health Care"},{"issue":"17","key":"10.1016\/j.semdp.2025.150960_bib0012","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.3390\/cancers13174378","article-title":"Performance of narrow band imaging (NBI) and photodynamic diagnosis (pdd) fluorescence imaging compared to white light cystoscopy (WLC) in detecting non-muscle invasive bladder cancer: a systematic review and lesion-level diagnostic meta-analysis","volume":"13","author":"Russo","year":"2021","journal-title":"Cancers"},{"issue":"11b","key":"10.1016\/j.semdp.2025.150960_bib0013","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2012.11500.x","article-title":"Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis","volume":"110","author":"Zheng","year":"2012","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11934-020-0966-5","article-title":"Blue Light Cystoscopy: indications and outcomes","volume":"21","author":"Pohar","year":"2020","journal-title":"Curr Urol Rep"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1756287213510590","article-title":"Blue-light cystoscopy in the evaluation of non-muscle-invasive bladder cancer","volume":"6","author":"Oude Elferink","year":"2014","journal-title":"Ther Adv Urol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0016","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.semdp.2025.150960_bib0017","series-title":"The Paris System For Reporting Urinary Cytology","first-page":"267","article-title":"The history of urinary cytology: the long and winding road to Paris 2.0","author":"Pambuccian","year":"2022"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0018","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.semdp.2025.150960_bib0019","series-title":"The Paris System For Reporting Urinary Cytology. 2nd ed","year":"2022"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.eururo.2019.10.010","article-title":"Non-visible haematuria for the detection of bladder, upper tract, and kidney cancer: an updated systematic review and meta-analysis","volume":"77","author":"Jubber","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO Guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0022","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5858\/arpa.2023-0010-CP","article-title":"The implementation of nongynecologic reporting systems in cytopathology laboratories is highly variable: analysis of data from a 2020 supplemental survey of participants in the college of american pathologists interlaboratory comparison program in nongyne","volume":"148","author":"VandenBussche","year":"2024","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0023","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/jpm12020170","article-title":"The Paris system for reporting urinary cytology: a meta-analysis","volume":"12","author":"Nikas","year":"2022","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0024","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/cyt.12538","article-title":"Urinary cytology and the Paris system for reporting urinary cytology: implications for urological management","volume":"29","author":"Gupta","year":"2018","journal-title":"Cytopathology"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cncy.21634","article-title":"Adequacy in voided urine cytology specimens: the role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma","volume":"124","author":"VandenBussche","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.semdp.2025.150960_bib0026","series-title":"Koss\u2019s Cytology of the Urinary Tract With Histopathologic Correlations","author":"Koss","year":"2012"},{"key":"10.1016\/j.semdp.2025.150960_bib0027","doi-asserted-by":"crossref","DOI":"10.14218\/JCTP.2022.00035","article-title":"The Paris System for Reporting Urinary Cytology: an Updated Review","author":"Chen","year":"2023","journal-title":"J Clin Transl Pathol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0028","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jasc.2017.04.001","article-title":"Adequacy of voided urine specimens prepared by thinprep and evaluated using the paris system for reporting urinary cytology","volume":"6","author":"Rezaee","year":"2017","journal-title":"J Am Soc Cytopathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0029","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cncy.21635","article-title":"Enough is enough: adequacy of voided urine cytology","volume":"124","author":"Barkan","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150960_bib0030","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1464-410X.2009.08650.x","article-title":"The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma","volume":"104","author":"Ordon","year":"2009","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.semdp.2025.150960_bib0031","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/dc.23621","article-title":"Causes of false-negative for high-grade urothelial carcinoma in urine cytology","volume":"44","author":"Lee","year":"2016","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0032","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00345-020-03171-6","article-title":"Diagnostic accuracy of ultrasonography, computed tomography, cystoscopy and cytology to detect urinary tract malignancies in patients with asymptomatic hematuria","volume":"39","author":"Fankhauser","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.semdp.2025.150960_bib0033","article-title":"Deintensification of treatment for low-grade bladder tumors: a collaborative review by the international bladder cancer group (IBCG)","author":"Contieri","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150960_bib0034","doi-asserted-by":"crossref","first-page":"9415","DOI":"10.18632\/oncotarget.24072","article-title":"Grade progression in urothelial carcinoma can occur with high or low mutational homology: a first-step toward tumor-specific care in initial low-grade bladder cancer","volume":"9","author":"Kittler","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.semdp.2025.150960_bib0035","series-title":"Diagnostic Pathology: Genitourinary. 2nd Editio","author":"Amin","year":"2017"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0036","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1309\/AJCPE1O9YKMRSQKG","article-title":"Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens","volume":"144","author":"McCroskey","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0037","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jasc.2014.10.006","article-title":"Is a consistent cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytologic specimens possible? A comparison between cytomorphologic features of low-grade urothelial carcinoma and non-neoplastic changes shows extensive ov","volume":"4","author":"McCroskey","year":"2015","journal-title":"J Am Soc Cytopathol"},{"issue":"16","key":"10.1016\/j.semdp.2025.150960_bib0038","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3390\/diagnostics13162625","article-title":"Diagnosis of low-grade urothelial neoplasm in the era of the second edition of the paris system for reporting urinary cytology","volume":"13","author":"Christofidis","year":"2023","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0039","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/JOC.JOC_193_18","article-title":"Is diagnosis of low-grade urothelial carcinoma possible in urine cytology?","volume":"38","author":"Bansal","year":"2021","journal-title":"J Cytol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0040","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1309\/XUVXFXMFPL7TELCE","article-title":"Urine cytology discrepancies","volume":"127","author":"Raab","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0041","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000326732","article-title":"Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings","volume":"46","author":"Chu","year":"2002","journal-title":"Acta Cytol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0042","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1097-0142(19940901)74:5<1621::AID-CNCR2820740521>3.0.CO;2-E","article-title":"Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis","volume":"74","author":"Raab","year":"1994","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.semdp.2025.150960_bib0043","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncy.21716","article-title":"The cytomorphological features of low-grade urothelial neoplasms vary by specimen type","volume":"124","author":"Zhang","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0044","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clgc.2020.07.011","article-title":"Bladder cancer: a comparison between non-urothelial variant histology and urothelial carcinoma across all stages and treatment modalities","volume":"19","author":"Deuker","year":"2021","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/bju.14995","article-title":"Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)","volume":"125","author":"Matulay","year":"2020","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0046","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cyt.12604","article-title":"Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system","volume":"29","author":"Rohilla","year":"2018","journal-title":"Cytopathology"},{"issue":"9","key":"10.1016\/j.semdp.2025.150960_bib0047","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cncy.22726","article-title":"Atypical urothelial cells classified according to the Paris system for reporting urinary cytology: a 2-year experience with histological correlation from a finnish tertiary care center\u2014low rate and high risk of malignancy","volume":"131","author":"P\u00f6yry","year":"2023","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0048","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cncy.22349","article-title":"Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris system for reporting urinary cytology: a single-institution study of more than 27,000 cases","volume":"129","author":"Tian","year":"2021","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0049","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jasc.2017.05.005","article-title":"Implementation of the Paris system for reporting urinary cytology results in lower atypical diagnostic rates","volume":"6","author":"Torous","year":"2017","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jasc.2020.09.002","article-title":"The paris system for reporting urinary cytology reduces atypia rates and does not alter the negative predictive value of urine cytology","volume":"10","author":"McIntire","year":"2021","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0051","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000452092","article-title":"Applying the paris system for reporting urine cytology increases the rate of atypical urothelial cells in benign cases: a need for patient management recommendations","volume":"61","author":"Granados","year":"2017","journal-title":"Acta Cytol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0052","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ajcp\/aqw127","article-title":"Impact of implementing the paris system for reporting urine cytology in the performance of urine cytology: a correlative study of 124 cases","volume":"146","author":"Hassan","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0053","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/cncy.21999","article-title":"One year of experience using the paris system for reporting urinary cytology","volume":"126","author":"Meilleroux","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0054","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cyt.12777","article-title":"The continual impact of the Paris System on urine cytology, a 3-year experience","volume":"31","author":"Stanzione","year":"2020","journal-title":"Cytopathology"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cyt.12780","article-title":"Two-year study on the application of the Paris system for urinary cytology in a cancer centre","volume":"31","author":"de Paula","year":"2020","journal-title":"Cytopathology"},{"key":"10.1016\/j.semdp.2025.150960_bib0056","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/cytojournal.cytojournal_30_19","article-title":"Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement","volume":"16","author":"Bakkar","year":"2019","journal-title":"Cytojournal"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0057","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cncy.21958","article-title":"Implementing The Paris system for reporting urinary cytology results in a decrease in the rate of the \u201catypical\u201d category and an increase in its prediction of subsequent high-grade urothelial carcinoma","volume":"126","author":"Wang","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0058","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jasc.2018.06.102","article-title":"The ability of the paris system to stratify the risk of high-grade urothelial carcinoma","volume":"7","author":"Xing","year":"2018","journal-title":"J Am Soc Cytopathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0059","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ajcp\/aqy043","article-title":"A single institutional experience with the paris system for reporting urinary cytology: correlation of cytology and histology in 194 cases","volume":"150","author":"Zare","year":"2018","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0060","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/cyt.12450","article-title":"Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features","volume":"28","author":"Suh","year":"2017","journal-title":"Cytopathology"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0061","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0062","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus calmette-guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150960_bib0063","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer \u2014 current status and future perspectives","volume":"20","author":"Maas","year":"2023","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0064","first-page":"41","article-title":"Urinary biomarkers in bladder cancer: a review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/iju.15338","article-title":"Urinary markers for bladder cancer diagnosis: a review of current status and future challenges","volume":"31","author":"Tomiyama","year":"2024","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0066","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000064872","article-title":"Qualitative determination of urinary human complement factor H-related protein (hcfHrp) in patients with bladder cancer, healthy controls, and patients with benign urologic disease","volume":"65","author":"Heicappell","year":"2000","journal-title":"Urol Int"},{"key":"10.1016\/j.semdp.2025.150960_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119718","article-title":"Nuclear matrix protein 22 in bladder cancer","volume":"560","author":"Cheng","year":"2024","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0068","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00345-022-04253-3","article-title":"Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review","volume":"41","author":"Soorojebally","year":"2023","journal-title":"World J Urol"},{"issue":"12","key":"10.1016\/j.semdp.2025.150960_bib0069","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/M15-0997","article-title":"Urinary biomarkers for diagnosis of bladder cancer","volume":"163","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.semdp.2025.150960_bib0070","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/dc.24531","article-title":"The predictive value of positive and suspicious urine cytology: are they different?","volume":"48","author":"Kuan","year":"2020","journal-title":"Diagn Cytopathol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150960_bib0071","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cncy.21764","article-title":"The positive predictive value of \u201csuspicious for high-grade urothelial carcinoma\u201d in urinary tract cytology specimens: a single-institution study of 665 cases","volume":"124","author":"Joudi","year":"2016","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"10.1016\/j.semdp.2025.150960_bib0072","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/dc.21573","article-title":"Urine cytology of micropapillary carcinoma of the urinary bladder","volume":"39","author":"Sakuma","year":"2011","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0073","first-page":"107","article-title":"Histologic variants of urothelial carcinoma: morphology, molecular features and clinical implications","volume":"6","author":"Alderson","year":"2020","journal-title":"Bl Cancer"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0074","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/dc.24331","article-title":"Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma","volume":"48","author":"Straccia","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.semdp.2025.150960_bib0075","unstructured":"National Comprehensive Cancer Network. Bladder Cancer. NCCN Guidelines for Patients. nccn.org\/patients\/guidelines\/content\/PDF\/bladder-patient.pdf. Published 2024. Accessed December 4, 2024."},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0076","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.euf.2019.03.012","article-title":"Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes","volume":"6","author":"Subiela","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"10","key":"10.1016\/j.semdp.2025.150960_bib0077","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/cncy.22446","article-title":"Challenges in recognizing urothelial carcinoma in situ with plasmacytoid features by urinary cytology","volume":"129","author":"Allison","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.semdp.2025.150960_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European association of urology guidelines on non\u2013muscle-invasive bladder cancer (tat1 and carcinoma in situ)\u2014a summary of the 2024 guidelines update","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0079","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajur.2016.05.001","article-title":"Narrow band imaging for bladder cancer","volume":"3","author":"Hsueh","year":"2016","journal-title":"Asian J Urol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/fjs.fjs_133_18","article-title":"Blue-light cystoscopy and narrow-band imaging in bladder cancer management","volume":"52","author":"Zang","year":"2019","journal-title":"Formos J Surg"},{"issue":"10","key":"10.1016\/j.semdp.2025.150960_bib0081","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11934-018-0833-9","article-title":"Enhanced Endoscopy in Bladder Cancer","volume":"19","author":"Pearce","year":"2018","journal-title":"Curr Urol Rep"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0082","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/crj.12217","article-title":"Delays for diagnosis and treatment of lung cancers: a systematic review","volume":"10","author":"Vinas","year":"2016","journal-title":"Clin Respir J"},{"issue":"8","key":"10.1016\/j.semdp.2025.150960_bib0083","article-title":"Blue light cystoscopy for the diagnosis of bladder cancer: results from the US prospective multicenter registry","volume":"36","author":"Daneshmand","year":"2018","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0084","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.juro.2017.11.096","article-title":"Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative, multicenter study","volume":"199","author":"Daneshmand","year":"2018","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0085","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","article-title":"Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma","volume":"108","author":"Messer","year":"2011","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0086","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cncy.22343","article-title":"A review of upper urinary tract cytology performance before and after the implementation of The Paris System","volume":"129","author":"Zhang","year":"2021","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0087","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAP.0b013e31817145a9","article-title":"Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting","volume":"15","author":"Gupta","year":"2008","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0088","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1309\/HC0U-8MEL-9GGV-G9EW","article-title":"Transitional cell carcinoma of the renal pelvis the diagnostic role of pelvic washings","volume":"117","author":"Witte","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0089","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.eururo.2010.04.026","article-title":"Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours","volume":"58","author":"Mian","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cncr.21456","article-title":"Comparison of ureteral washing and biopsy specimens in the community setting","volume":"108","author":"Renshaw","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.semdp.2025.150960_bib0091","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0090-4295(01)01307-3","article-title":"The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma","volume":"58","author":"Walsh","year":"2001","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.semdp.2025.150960_bib0092","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/cncy.22005","article-title":"Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas","volume":"126","author":"McIntire","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0093","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/dc.24127","article-title":"The utility of upper urinary tract urine cytology before and after application of the Paris system","volume":"47","author":"Simon","year":"2019","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0094","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jasc.2020.08.001","article-title":"High-grade urothelial carcinoma in urine cytology: different spaces \u2013 different faces, highlighting morphologic variance","volume":"10","author":"McIntire","year":"2021","journal-title":"J Am Soc Cytopathol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jasc.2018.07.006","article-title":"Utility of The Paris system for reporting urinary cytology in upper urinary tract specimens","volume":"7","author":"Xing","year":"2018","journal-title":"J Am Soc Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0096","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jasc.2020.10.003","article-title":"High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology","volume":"10","author":"Renshaw","year":"2021","journal-title":"J Am Soc Cytopathol"},{"issue":"9","key":"10.1016\/j.semdp.2025.150960_bib0097","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/dc.24809","article-title":"Nuclear hypochromasia: shedding light on the \u201clightness\u201d of high-grade urothelial carcinoma","volume":"49","author":"Stern","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.semdp.2025.150960_bib0098","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejrad.2017.10.021","article-title":"Upper tract urothelial cancer","volume":"98","author":"Froemming","year":"2018","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0099","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2023 Update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.semdp.2025.150960_bib0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11912-021-01179-8","article-title":"Management of upper tract urothelial carcinoma","volume":"24","author":"Shvero","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.semdp.2025.150960_bib0101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2016.04.030","article-title":"Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature","volume":"96","author":"Potretzke","year":"2016","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0102","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","article-title":"Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO Guideline","volume":"209","author":"Coleman","year":"2023","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.semdp.2025.150960_bib0103","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1089\/end.2013.0220","article-title":"Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps","volume":"27","author":"Kleinmann","year":"2013","journal-title":"J Endourol"},{"issue":"3","key":"10.1016\/j.semdp.2025.150960_bib0104","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5858\/arpa.2012-0136-OA","article-title":"Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma","volume":"137","author":"Vashistha","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.semdp.2025.150960_bib0105","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.semdp.2025.150960_bib0106","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.22.00763","article-title":"Multicenter phase ii clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma","volume":"41","author":"Coleman","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.24.00340","article-title":"Adjuvant nivolumab in high-risk muscle-invasive urothelial carcinoma: expanded efficacy from checkmate 274","volume":"43","author":"Galsky","year":"2025","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.semdp.2025.150960_bib0108","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.23.01659","article-title":"Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: final results of the POUT Trial","volume":"42","author":"Birtle","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0109","article-title":"Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0110","article-title":"High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy","volume":"32","author":"Raman","year":"2014","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00345-018-2421-5","article-title":"Update of the international consultation on urological diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder","volume":"37","author":"Alanee","year":"2019","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.semdp.2025.150960_bib0112","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0302-2838(03)00416-0","article-title":"Malignant non-urothelial neoplasms of the urinary bladder: a review","volume":"44","author":"Dahm","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.semdp.2025.150960_bib0113","article-title":"Utility of the Paris system for reporting urinary cytology in patients with hpv-positive urinary tract carcinoma","author":"Tanaka","year":"2024","journal-title":"Cancer Cytopathol"},{"issue":"8","key":"10.1016\/j.semdp.2025.150960_bib0114","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cncy.22816","article-title":"Atypical squamous cells in urine cytology are associated with a significant risk of high-grade malignancy","volume":"132","author":"Ho","year":"2024","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.urology.2006.08.1107","article-title":"Nonurothelial cancer of the bladder","volume":"69","author":"Abol-Enein","year":"2007","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.semdp.2025.150960_bib0116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jasc.2018.11.001","article-title":"Cell block preparation in urine cytology: examination of utility and workflow in an academic practice","volume":"8","author":"Dantey","year":"2019","journal-title":"J Am Soc Cytopathol"},{"issue":"10","key":"10.1016\/j.semdp.2025.150960_bib0117","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cncy.22730","article-title":"Utility and performance of cell blocks in urine cytology: experience at three teaching hospitals","volume":"131","author":"Greenland","year":"2023","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.semdp.2025.150960_bib0118","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jasc.2020.08.003","article-title":"Cell blocks in urine cytopathology: do they add value to the diagnosis? A pilot study","volume":"10","author":"Wilson","year":"2021","journal-title":"J Am Soc Cytopathol"},{"issue":"9","key":"10.1016\/j.semdp.2025.150960_bib0119","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/cncy.22034","article-title":"Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks","volume":"126","author":"Chan","year":"2018","journal-title":"Cancer Cytopathol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257025000966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:54:40Z","timestamp":1763369680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257025000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0740257025000966"],"URL":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150960","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging Perspectives: Integrating urologist and cytopathologist insights of urine cytology","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semdp.2025.150960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150960"}}